Lessons to be learned from early psychedelic therapy in Denmark.
Open Access
- 20 June 2017
- journal article
- editorial
- Published by Taylor & Francis in Nordic Journal of Psychiatry
- Vol. 71 (7), 487-488
- https://doi.org/10.1080/08039488.2017.1336252
Abstract
No abstract availableThis publication has 14 references indexed in Scilit:
- Rapid and sustained symptom reduction following psilocybin treatment for anxiety and depression in patients with life-threatening cancer: a randomized controlled trialJournal of Psychopharmacology, 2016
- Psilocybin produces substantial and sustained decreases in depression and anxiety in patients with life-threatening cancer: A randomized double-blind trialJournal of Psychopharmacology, 2016
- Clinical applications of hallucinogens: A review.Experimental and Clinical Psychopharmacology, 2016
- Long-term follow-up of psilocybin-facilitated smoking cessationThe American Journal of Drug and Alcohol Abuse, 2016
- Psilocybin with psychological support for treatment-resistant depression: an open-label feasibility studyThe Lancet Psychiatry, 2016
- Antidepressive, anxiolytic, and antiaddictive effects of ayahuasca, psilocybin and lysergic acid diethylamide (LSD): a systematic review of clinical trials published in the last 25 yearsTherapeutic Advances in Psychopharmacology, 2016
- Antidepressant Effects of a Single Dose of Ayahuasca in Patients With Recurrent DepressionJournal of Clinical Psychopharmacology, 2016
- Psilocybin-assisted treatment for alcohol dependence: A proof-of-concept studyJournal of Psychopharmacology, 2015
- Safety and Efficacy of Lysergic Acid Diethylamide-Assisted Psychotherapy for Anxiety Associated With Life-threatening DiseasesJournal of Nervous & Mental Disease, 2014
- Human hallucinogen research: guidelines for safetyJournal of Psychopharmacology, 2008